ATC code L04
| ATC codes | |||
|---|---|---|---|
| L Antineoplastic and immunomodulating agents | |||
| L01 Antineoplastic agents | |||
| L02 Endocrine therapy | |||
| L03 Immunostimulants | |||
| L04 Immunosuppressants | |||
|
| |||
ATC code L04 Immunosuppressants is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L04 is part of the anatomical group L Antineoplastic and immunomodulating agents.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QL04...[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
L04A Immunosuppressants
L04AA Selective immunosuppressants
- L04AA02 Muromonab-CD3
- L04AA03 Antilymphocyte immunoglobulin (horse)
- L04AA04 Antithymocyte immunoglobulin (rabbit)
- L04AA06 Mycophenolic acid
- L04AA10 Sirolimus
- L04AA13 Leflunomide
- L04AA15 Alefacept
- L04AA18 Everolimus
- L04AA19 Gusperimus
- L04AA21 Efalizumab
- L04AA22 Abetimus
- L04AA23 Natalizumab
- L04AA24 Abatacept
- L04AA25 Eculizumab
- L04AA26 Belimumab
- L04AA27 Fingolimod
- L04AA28 Belatacept
- L04AA29 Tofacitinib
- L04AA31 Teriflunomide
- L04AA32 Apremilast
- L04AA33 Vedolizumab
- L04AA34 Alemtuzumab
- L04AA35 Begelomab
L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
- L04AB01 Etanercept
- L04AB02 Infliximab
- L04AB03 Afelimomab
- L04AB04 Adalimumab
- L04AB05 Certolizumab pegol
- L04AB06 Golimumab
L04AC Interleukin inhibitors
- L04AC01 Daclizumab
- L04AC02 Basiliximab
- L04AC03 Anakinra
- L04AC04 Rilonacept
- L04AC05 Ustekinumab
- L04AC06 Mepolizumab
- L04AC07 Tocilizumab
- L04AC08 Canakinumab
- L04AC09 Briakinumab
- L04AC10 Secukinumab
- L04AC11 Siltuximab
- L04AC12 Brodalumab
L04AD Calcineurin inhibitors
- L04AD01 Ciclosporin
- L04AD02 Tacrolimus
- L04AD03 Voclosporin
L04AX Other immunosuppressants
- L04AX01 Azathioprine
- L04AX02 Thalidomide
- L04AX03 Methotrexate
- L04AX04 Lenalidomide
- L04AX05 Pirfenidone
- L04AX06 Pomalidomide
References
- ↑ "ATC/DDD Index 2016: code L04". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2016: code QL04". WHO Collaborating Centre for Drug Statistics Methodology.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, February 23, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.